Introduction The coxib controversies

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.13, Iss.4, 2005-09, pp. : 331-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk

Current Medicinal Chemistry, Vol. 24, Iss. 30, 2017-10 ,pp. : 3218-3230

Bentham Science Publishers

Access to resources Recommend Favorite

Clopidogrel: The Data, the Experience, and the Controversies

By Sadanandan Saihari

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 6, 2012-12 ,pp. : 361-374

Adis International

Access to resources Recommend Favorite

Controversies in the management of ectopic pregnancy

By Cheong Ying Li TC

Reproductive BioMedicine Online, Vol. 15, Iss. 4, 2007-10 ,pp. : 396-402

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Controversies in the Management of Oropharynx Cancer

By Worden Francis P. Ha Huan

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 7, 2008-08 ,pp. : 707-714

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The Lyme disease controversies continue

By Pavia Charles S

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1615-1620

Informa Healthcare

Access to resources Recommend Favorite